Insider · CIK 0002064884
Imran Nizamudin Alibhai
Files at TVRD (Cara Therapeutics, Inc.). First filing -, latest -.
In brief
Imran Nizamudin Alibhai files SEC Form 4 as CEO and director at TVRD (Cara Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Imran Nizamudin Alibhai has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | TVRD Cara Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +115,000 | $0.00 | $0 | 115,000 | Feb 2, 2026 |
| Dec 16, 2025 | TVRD Cara Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +47,500 | $0.00 | $0 | 47,500 | Dec 18, 2025 |
| Apr 17, 2025 | TVRD Cara Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +182,320 | $0.00 | $0 | 182,320 | Apr 21, 2025 |
| Apr 15, 2025 | TVRD Cara Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +207,881 | - | - | 207,881 | Apr 17, 2025 |
| Apr 15, 2025 | TVRD Cara Therapeutics, Inc. | AGrant or award Employee Stock Optyion (right to buy)derivative | +2,011 | - | - | 2,011 | Apr 17, 2025 |
| Apr 15, 2025 | TVRD Cara Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +160,940 | - | - | 160,940 | Apr 17, 2025 |
Questions about Imran Nizamudin Alibhai
Answered from the filings on this page, as of the latest one.
Is Imran Nizamudin Alibhai buying or selling?
Imran Nizamudin Alibhai has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Imran Nizamudin Alibhai's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Imran Nizamudin Alibhai has 0.
Where does Imran Nizamudin Alibhai file Form 4?
Imran Nizamudin Alibhai has filed Form 4 at TVRD (Cara Therapeutics, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.